![Luciana Borio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Luciana Borio
Director/Board Member at
EAGLE PHARMACEUTICALS, INC.
Net worth: 564 805 $ as of 30/09/2026
Profile
Dr. Luciana Borio, MD, is an Independent Director at Insulet Corp., a Venture Partner at ARCH Venture Partners LLC and an Independent Director at Eagle Pharmaceuticals, Inc. She is on the Board of Directors at Noblis, Inc., Insulet Corp., Eagle Pharmaceuticals, Inc. and Paradigm Health, Inc. Dr. Borio was previously employed as a Senior Vice President by In-Q-Tel, Inc., a Director-Medical & Biodefense Preparedness Policy by National Security Council, a Chief Scientist by US Food & Drug Administration, and a Senior Associates by The UPMC Center for Health Security.
She received her undergraduate degree from George Washington University and a doctorate degree from George Washington University School of Medicine & Health.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INSULET CORPORATION 0.01% | 03/06/2026 | 4,329 ( 0.01% ) | 564 805 $ | 30/09/2026 |
Luciana Borio active positions
| Companies | Position | Start |
|---|---|---|
| EAGLE PHARMACEUTICALS, INC. | Director/Board Member | 28/04/2021 |
| INSULET CORPORATION | Director/Board Member | 18/10/2021 |
Noblis, Inc.
 Noblis, Inc. Miscellaneous Commercial ServicesCommercial Services Provides science based technology and strategy consulting services | Director/Board Member | 25/10/2021 |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private Equity Investor | 01/07/2021 |
Paradigm Health, Inc.
 Paradigm Health, Inc. Packaged SoftwareTechnology Services Develops platform for clinical research | Director/Board Member | - |
Former positions of Luciana Borio
| Companies | Position | End |
|---|---|---|
In-Q-Tel, Inc.
 In-Q-Tel, Inc. Financial ConglomeratesFinance Alternative investment manager | Corporate Officer/Principal | 01/01/2020 |
National Security Council | Corporate Officer/Principal | 01/01/2019 |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01/01/2017 |
Johns Hopkins Center For Health Security
 Johns Hopkins Center For Health Security Miscellaneous Commercial ServicesCommercial Services Conducts research and policy analysis | Corporate Officer/Principal | 01/10/2008 |
Education of Luciana Borio
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
74
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Eagle Pharmaceuticals, Inc.
 Eagle Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialize injectable products primarily in the metabolic critical care and oncology | Health Technology |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Noblis, Inc.
Noblis, Inc. Miscellaneous Commercial ServicesCommercial Services Provides science based technology and strategy consulting services | Commercial Services |
Insulet Corp.
 Insulet Corp. Medical SpecialtiesHealth Technology Manufactures, develops and markets insulin infusion systems | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
In-Q-Tel, Inc.
In-Q-Tel, Inc. Financial ConglomeratesFinance Alternative investment manager | Finance |
Johns Hopkins Center For Health Security
Johns Hopkins Center For Health Security Miscellaneous Commercial ServicesCommercial Services Conducts research and policy analysis | Commercial Services |
National Security Council | |
George Washington University School of Medicine & Health
 George Washington University School of Medicine & Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paradigm Health, Inc.
Paradigm Health, Inc. Packaged SoftwareTechnology Services Develops platform for clinical research | Technology Services |
- Stock Market
- Insiders
- Luciana Borio
